{"id":1237,"date":"2020-01-15T11:01:46","date_gmt":"2020-01-15T09:01:46","guid":{"rendered":"https:\/\/xavron.com.ua\/?post_type=publications&p=1237"},"modified":"2023-04-11T16:56:15","modified_gmt":"2023-04-11T13:56:15","slug":"zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu","status":"publish","type":"publications","link":"https:\/\/xavron.com.ua\/en\/publications\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\/","title":{"rendered":"The use of the drug Xavron (Edaravon) in the complex treatment of patients with ischemic stroke in combination with thrombolytic therapy"},"content":{"rendered":"

Resume.<\/strong>\u00a0The article describes the experience of the early use of Xavron (Edaravon) in patients with ischemic stroke in combination with thrombolytic therapy (TLT). These studies indicate greater efficacy of using Edaravon in combination with TLT in the treatment of ischemic stroke. When using the drug Xavron side effects of the drug was not observed.<\/p>\n","protected":false},"featured_media":614,"parent":0,"menu_order":0,"template":"","publ-cat":[33],"publ-tags":[255,53],"class_list":["post-1237","publications","type-publications","status-publish","has-post-thumbnail","hentry","publ-cat-when-stroke-en","publ-tags-comprehensive-treatment","publ-tags-edaravone"],"acf":[],"yoast_head":"\nThe use of the drug Xavron (Edaravon) in the complex treatment of patients with ischemic stroke in combination with thrombolytic therapy - Xavron<\/title>\n<meta name=\"description\" content=\"Resume.\u00a0The article describes the experience of the early use of Xavron (Edaravon) in patients with ischemic stroke in combination with thrombolytic therap\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xavron.com.ua\/en\/publications\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The use of the drug Xavron (Edaravon) in the complex treatment of patients with ischemic stroke in combination with thrombolytic therapy - Xavron\" \/>\n<meta property=\"og:description\" content=\"Resume.\u00a0The article describes the experience of the early use of Xavron (Edaravon) in patients with ischemic stroke in combination with thrombolytic therap\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xavron.com.ua\/en\/publications\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\/\" \/>\n<meta property=\"og:site_name\" content=\"Xavron\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-11T13:56:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/xavron.com.ua\/wp-content\/uploads\/2023\/04\/ksavron-u-poyednanni-z-trombolitychnoyu-terapiyeyu-leskiv-neuro3_2019.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"696\" \/>\n\t<meta property=\"og:image:height\" content=\"929\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\\\/\",\"url\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\\\/\",\"name\":\"The use of the drug Xavron (Edaravon) in the complex treatment of patients with ischemic stroke in combination with thrombolytic therapy - Xavron\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xavron.com.ua\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ksavron-u-poyednanni-z-trombolitychnoyu-terapiyeyu-leskiv-neuro3_2019.jpg\",\"datePublished\":\"2020-01-15T09:01:46+00:00\",\"dateModified\":\"2023-04-11T13:56:15+00:00\",\"description\":\"Resume.\u00a0The article describes the experience of the early use of Xavron (Edaravon) in patients with ischemic stroke in combination with thrombolytic therap\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\\\/#primaryimage\",\"url\":\"https:\\\/\\\/xavron.com.ua\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ksavron-u-poyednanni-z-trombolitychnoyu-terapiyeyu-leskiv-neuro3_2019.jpg\",\"contentUrl\":\"https:\\\/\\\/xavron.com.ua\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ksavron-u-poyednanni-z-trombolitychnoyu-terapiyeyu-leskiv-neuro3_2019.jpg\",\"width\":696,\"height\":929},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Xavron\",\"item\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications\",\"item\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"When Stroke\",\"item\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publ-cat\\\/when-stroke-en\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"The use of the drug Xavron (Edaravon) in the complex treatment of patients with ischemic stroke in combination with thrombolytic therapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/\",\"name\":\"Xavron\",\"description\":\"\u0411\u043b\u043e\u043a\u0430\u0442\u043e\u0440 \u0406\u0448\u0435\u043c\u0456\u0447\u043d\u043e\u0433\u043e \u041a\u0430\u0441\u043a\u0430\u0434\u0443\",\"publisher\":{\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/#organization\",\"name\":\"Xavron\",\"url\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/xavron.com.ua\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/xavron.png\",\"contentUrl\":\"https:\\\/\\\/xavron.com.ua\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/xavron.png\",\"width\":389,\"height\":58,\"caption\":\"Xavron\"},\"image\":{\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The use of the drug Xavron (Edaravon) in the complex treatment of patients with ischemic stroke in combination with thrombolytic therapy - Xavron","description":"Resume.\u00a0The article describes the experience of the early use of Xavron (Edaravon) in patients with ischemic stroke in combination with thrombolytic therap","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xavron.com.ua\/en\/publications\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\/","og_locale":"en_US","og_type":"article","og_title":"The use of the drug Xavron (Edaravon) in the complex treatment of patients with ischemic stroke in combination with thrombolytic therapy - Xavron","og_description":"Resume.\u00a0The article describes the experience of the early use of Xavron (Edaravon) in patients with ischemic stroke in combination with thrombolytic therap","og_url":"https:\/\/xavron.com.ua\/en\/publications\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\/","og_site_name":"Xavron","article_modified_time":"2023-04-11T13:56:15+00:00","og_image":[{"width":696,"height":929,"url":"https:\/\/xavron.com.ua\/wp-content\/uploads\/2023\/04\/ksavron-u-poyednanni-z-trombolitychnoyu-terapiyeyu-leskiv-neuro3_2019.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/xavron.com.ua\/en\/publications\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\/","url":"https:\/\/xavron.com.ua\/en\/publications\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\/","name":"The use of the drug Xavron (Edaravon) in the complex treatment of patients with ischemic stroke in combination with thrombolytic therapy - Xavron","isPartOf":{"@id":"https:\/\/xavron.com.ua\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/xavron.com.ua\/en\/publications\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\/#primaryimage"},"image":{"@id":"https:\/\/xavron.com.ua\/en\/publications\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\/#primaryimage"},"thumbnailUrl":"https:\/\/xavron.com.ua\/wp-content\/uploads\/2023\/04\/ksavron-u-poyednanni-z-trombolitychnoyu-terapiyeyu-leskiv-neuro3_2019.jpg","datePublished":"2020-01-15T09:01:46+00:00","dateModified":"2023-04-11T13:56:15+00:00","description":"Resume.\u00a0The article describes the experience of the early use of Xavron (Edaravon) in patients with ischemic stroke in combination with thrombolytic therap","breadcrumb":{"@id":"https:\/\/xavron.com.ua\/en\/publications\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xavron.com.ua\/en\/publications\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xavron.com.ua\/en\/publications\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\/#primaryimage","url":"https:\/\/xavron.com.ua\/wp-content\/uploads\/2023\/04\/ksavron-u-poyednanni-z-trombolitychnoyu-terapiyeyu-leskiv-neuro3_2019.jpg","contentUrl":"https:\/\/xavron.com.ua\/wp-content\/uploads\/2023\/04\/ksavron-u-poyednanni-z-trombolitychnoyu-terapiyeyu-leskiv-neuro3_2019.jpg","width":696,"height":929},{"@type":"BreadcrumbList","@id":"https:\/\/xavron.com.ua\/en\/publications\/zastosuvannya-preparatu-ksavron-edaravon-u-kompleksnomu-likuvanni-pacziyentiv-z-ishemichnym-insultom-u-poyednanni-z-trombolitychnoyu-terapiyeyu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Xavron","item":"https:\/\/xavron.com.ua\/en\/"},{"@type":"ListItem","position":2,"name":"Publications","item":"https:\/\/xavron.com.ua\/en\/publications\/"},{"@type":"ListItem","position":3,"name":"When Stroke","item":"https:\/\/xavron.com.ua\/en\/publ-cat\/when-stroke-en\/"},{"@type":"ListItem","position":4,"name":"The use of the drug Xavron (Edaravon) in the complex treatment of patients with ischemic stroke in combination with thrombolytic therapy"}]},{"@type":"WebSite","@id":"https:\/\/xavron.com.ua\/en\/#website","url":"https:\/\/xavron.com.ua\/en\/","name":"Xavron","description":"\u0411\u043b\u043e\u043a\u0430\u0442\u043e\u0440 \u0406\u0448\u0435\u043c\u0456\u0447\u043d\u043e\u0433\u043e \u041a\u0430\u0441\u043a\u0430\u0434\u0443","publisher":{"@id":"https:\/\/xavron.com.ua\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xavron.com.ua\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/xavron.com.ua\/en\/#organization","name":"Xavron","url":"https:\/\/xavron.com.ua\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xavron.com.ua\/en\/#\/schema\/logo\/image\/","url":"https:\/\/xavron.com.ua\/wp-content\/uploads\/2023\/04\/xavron.png","contentUrl":"https:\/\/xavron.com.ua\/wp-content\/uploads\/2023\/04\/xavron.png","width":389,"height":58,"caption":"Xavron"},"image":{"@id":"https:\/\/xavron.com.ua\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/xavron.com.ua\/en\/wp-json\/wp\/v2\/publications\/1237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xavron.com.ua\/en\/wp-json\/wp\/v2\/publications"}],"about":[{"href":"https:\/\/xavron.com.ua\/en\/wp-json\/wp\/v2\/types\/publications"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xavron.com.ua\/en\/wp-json\/wp\/v2\/media\/614"}],"wp:attachment":[{"href":"https:\/\/xavron.com.ua\/en\/wp-json\/wp\/v2\/media?parent=1237"}],"wp:term":[{"taxonomy":"publ-cat","embeddable":true,"href":"https:\/\/xavron.com.ua\/en\/wp-json\/wp\/v2\/publ-cat?post=1237"},{"taxonomy":"publ-tags","embeddable":true,"href":"https:\/\/xavron.com.ua\/en\/wp-json\/wp\/v2\/publ-tags?post=1237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}